Posts Tagged ‘Dendreon Halted’

Dendreon (DNDN) Halted, Resumes Trading

10:45am (EST) Shares of Dendreon (DNDN, $11.03, up $3.43) were halted briefly after circuit breakers triggered on pending news.  Shares have resumed trading after the company said sales of its prostate cancer drug, Provenge, more than tripled for the fourth quarter to $82 million compared to last year.  The companyRead more

More

MomentumOptionsTrading.com News Flash for 11/17/10

Dendreon (DNDN) Halted 10:30am (EST) Shares of Dendreon (DNDN, $35.87, no change) have been halted today due to pending news concerning its cancer drug, Provenge.  Many of our subscribers know we have been following this company for years and we were one of the first believers of the company whenRead more

More

Dendreon (DNDN) HALTED, Akamai (AKAM) Aces Earnings

1:05pm (EST)    The bulls are brushing off Tuesday’s debacle in a big way as they are carrying the market back to the highs prior to the Greece and Portugal news. The market is showing strong gains after better-than-expected earnings reports from a number of companies and after weekly U.S. jobless claimsRead more

More

Dendreon Halted

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.